LivaNova PLC Livanova Plc: Transaction In Own Shares
October 18 2016 - 2:00AM
UK Regulatory
TIDMLIVN
LONDON, Oct. 18, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (the "Company" or
"LivaNova") announces on 18 October 2016, the repurchase of 11,200
ordinary shares on 17 October 2016 as a part of the US $150 million
share repurchase programme previously announced on 2 August 2016. The
highest price paid per ordinary share was $56.97 and the lowest price
paid per share was $56.48. The repurchased shares will be cancelled.
As of 17 October 2016, after giving effect to the cancellation of these
ordinary shares, the number of shares of ordinary shares outstanding
would be 48,814,221, and the total number of voting rights in the
Company would be 48,814,221, which may be used by shareholders as the
denominator for the calculations by which they will determine if they
are required to notify their interest in, or a change to their interest
in the Company under the FCA's Disclosure Guidance and Transparency
Rules.
The above purchases were made by Merrill Lynch, Pierce, Fenner & Smith
Incorporated.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger
of Sorin S.p.A, a leader in the treatment of cardiovascular diseases,
and Cyberonics Inc., a medical device company with core expertise in
neuromodulation. LivaNova transforms medical innovation into meaningful
solutions for the benefit of patients, healthcare professionals, and
healthcare systems. The Company employs approximately 4,600 employees
worldwide and is headquartered in London, U.K. With a presence in more
than 100 countries, LivaNova operates as three business units: Cardiac
Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating
headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.),
respectively.
LivaNova is listed on NASDAQ and listed on the Official List of the UK's
Financial Conduct Authority and traded on London Stock Exchange (LSE)
under the ticker symbol "LIVN".
For more information, please visit www.livanova.com, or contact:
Investor Relations and Media
Karen King
Vice President, Investor Relations & Corporate Communications
Phone: +1 (281) 228-7262
Fax: +1 (281) 218-9332
e-mail: corporate.communications@livanova.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: LivaNova PLC via Globenewswire
(END) Dow Jones Newswires
October 18, 2016 02:00 ET (06:00 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Livanova (LSE:LIVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Livanova (LSE:LIVN)
Historical Stock Chart
From Apr 2023 to Apr 2024